Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
RESEARCH TOOLSreports
Holding DRUG?
Track your performance easily
Bright Minds Biosciences (DRUG) Ownership Overview
28.60% Insiders
2.63% Other Institutional Investors
0.04% ETFs
68.73% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. , 28.60% is owned by Insiders, and 68.73% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 11, 2024 | Jan Torleif Pedersen Chief Scientific Officer | xxxxxxxxxxxxx | C$1411795 |
| Nov 14, 2024 | Nils Bottler Non Executive,director | xxxxxxxxxxxxx | $653408 |
| Nov 12, 2024 | Ryan Cheung Chief Financial Officer | xxxxxxxxxxxxx | C$399010 |
| Nov 11, 2024 | Nils Bottler Non Executive,director | xxxxxxxxxxxxx | $248975 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,059,331 | Insider | 15.25% | 40,943,143 | |
| 674,900 | Insider | 9.71% | 26,084,885 | |
| 193,549 | Insider | 2.79% | 7,480,669 | |
| 35,000 | Insider | 0.50% | 1,352,750 | |
| 19,750 | Insider | 0.28% | 763,338 | |
| 5,000 | Insider | 0.07% | 193,250 | |
| 3,048 | Institution | 0.04% | 117,805 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Bright Minds Biosciences (DRUG)?
According to the latest TipRanks data, approximately 2.63% of the company's stock is held by institutional investors, 28.60% is held by insiders, and 68.73% is held by retail investors.
What percentage of Bright Minds Biosciences (DRUG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.63% of Bright Minds Biosciences (DRUG) stock is held by institutional investors.
What percentage of Bright Minds Biosciences (DRUG) stock is held by retail investors?
According to the latest TipRanks data, approximately 68.73% of Bright Minds Biosciences (DRUG) stock is held by retail investors.
Who owns the most shares of Bright Minds Biosciences (DRUG)?
Cormorant Asset Management LP owns the most shares of Bright Minds Biosciences (DRUG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.